Targeting the Mechanism of c-Mpl Exon-Inclusion through Antisense Oligonucleotides Yields a Dominant Negative Isoform
Sakiko Suzuki(University of Massachusetts Chan Medical School), Glen Raffel(University of Massachusetts Chan Medical School), Ronny R. Racine(University of Massachusetts Chan Medical School), Jeffrey A. Bailey(John Brown University), Cliff Odour(University of Massachusetts Chan Medical School), Michael P. Moazami(University of Massachusetts Chan Medical School), Nathan A. Manalo(University of Massachusetts Chan Medical School), Jonathan K. Watts(University of Massachusetts Chan Medical School), Neeraj Saini(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
|Nature Medicine|2023|226
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide
|Nature Medicine|2021|173
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147